Sensus Healthcare, Inc.

For the period ended Jun 30, 2026. Filed Aug 14, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 14, 2026

SRTS$3.30+3.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Loss (unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF LOSS

For the Three Months Ended · For the Six Months Ended
	June 30,		June 30,
(in thousands, except shares and per share data)	2026	2025	2026	2025
Revenues	$2,290	$7,315	$5,684	$15,659
Cost of sales	1,521	4,412	3,924	8,403
Gross profit	769	2,903	1,760	7,256
Operating expenses
General and administrative	1,786	1,986	3,827	4,193
Selling and marketing	1,054	1,389	2,771	3,575
Research and development	1,109	1,471	2,699	4,077
Total operating expenses	3,949	4,846	9,297	11,845
Loss from operations	(3,180)	(1,943)	(7,537)	(4,589)
Other income:
Interest income, net	117	183	241	367
Other income, net	117	183	241	367
Loss before income tax	(3,063)	(1,760)	(7,296)	(4,222)
Provision for (benefit from) income taxes	5,686	(723)	4,079	(613)
Net loss	$(8,749)	$(1,037)	$(11,375)	$(3,609)
Net loss per share – basic	$(0.53)	$(0.06)	$(0.69)	$(0.22)
diluted	$(0.53)	$(0.06)	$(0.69)	$(0.22)
Weighted average number of shares used in
computing net loss per share – basic	16,462,059	16,320,036	16,462,355	16,330,891
diluted	16,462,059	16,320,036	16,462,355	16,330,891

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.